LifeMD, Inc. (LFMD) Tops Q1 EPS by 24c

LifeMD, Inc. (NASDAQ: LFMD) reported Q1 EPS of $0.06, $0.24 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $33.1 million versus the consensus estimate of $34.52 million.

GUIDANCE:

LifeMD, Inc. sees FY2023 revenue of $140-150 million, versus the consensus of $146 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c